NEWS
Our Latest News
ARCHIMED acquires Jeisys Medical, a leading developer of aesthetic medicine devices
ARCHIMED initiates the delisting from Korea Exchange of shares in Jeisys Medical, a leading developer of aesthetic medicine devices, after acquiring Jeisys Medical via change-of-control transactions, including public tenders.
Primo sponsors the Executive Master in Management specialized in Healthcare Business
December
9,
2016
En quête d’entreprises profitables
November
14,
2016
ARCHIMED buys four companies; HIS, Fytexia, Polyplus, and Micromed
September
20,
2016
ARCHIMED acquires Deallus Consulting
November
9,
2015
368